- Home
- AMPX vs SANA Comparison
AMPX vs SANA Comparison
Compare AMPX & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMPX | SANA |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | United States | United States |
| Employees | 108 | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AMPX | SANA |
|---|---|---|
| Price | $14.82 | $2.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $19.43 | $7.60 |
| AVG Volume (30 Days) | ★ 9.4M | 2.6M |
| Earning Date | 03-04-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.24 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $70.54 | N/A |
| Revenue Next Year | $66.63 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.97 | $1.27 |
| 52 Week High | $19.76 | $6.55 |
Technical Indicators
Market Signals| Indicator | AMPX | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 44.15 | 30.02 |
| Support Level | $10.00 | N/A |
| Resistance Level | $16.03 | $3.36 |
| Average True Range (ATR) | 1.33 | 0.19 |
| MACD | -0.52 | -0.02 |
| Stochastic Oscillator | 3.14 | 2.54 |
Price Performance
Historical ComparisonAbout AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.